I would choose healthcare reform, particularly companies exposed to Medicaid and ACA insurance markets.
The opportunity is not simply increased healthcare funding. It is reduced policy uncertainty. Centene ($CNC), Molina Healthcare ($MOH), and HCA Healthcare ($HCA) could benefit if Medicaid cuts are delayed or ACA subsidies restored.
However, political promises are not earnings growth. Senate voting requirements and Trump's veto power make sweeping reforms difficult. The new Congress also takes office only in January 2027.
I would monitor legislative progress, medical cost ratios, and earnings guidance rather than chase election-driven rallies.
The real opportunity is finding companies whose profits can improve even if only part of the proposed reforms becomes reality.
@Tiger_comments [真香]
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
